IgE-FcεRI protein-protein interaction as a therapeutic target against allergic asthma: An updated review.

Fuente: PubMed
Enregistré dans:
Détails bibliographiques
Auteurs principaux: Liu, Yan-Jun, Wang, Hui-Ying, Wang, Ran, Yu, Jing, Shi, Jin-Jin, Chen, Ru-Yi, Yang, Guan-Jun, Chen, Jiong
Format: Artículo científico
Langue:en
Publié: International journal of biological macromolecules 2025
Sujets:
Accès en ligne:
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
_version_ 1868266275361259520
author Liu, Yan-Jun
Wang, Hui-Ying
Wang, Ran
Yu, Jing
Shi, Jin-Jin
Chen, Ru-Yi
Yang, Guan-Jun
Chen, Jiong
author_facet Liu, Yan-Jun
Wang, Hui-Ying
Wang, Ran
Yu, Jing
Shi, Jin-Jin
Chen, Ru-Yi
Yang, Guan-Jun
Chen, Jiong
Liu, Yan-Jun
Wang, Hui-Ying
Wang, Ran
Yu, Jing
Shi, Jin-Jin
Chen, Ru-Yi
Yang, Guan-Jun
Chen, Jiong
collection PubMed - marine biology
contents IgE-FcεRI protein-protein interaction as a therapeutic target against allergic asthma: An updated review. Liu, Yan-Jun Wang, Hui-Ying Wang, Ran Yu, Jing Shi, Jin-Jin Chen, Ru-Yi Yang, Guan-Jun Chen, Jiong Humans Immunoglobulin E Receptors, IgE Asthma Animals Protein Binding Mast Cells In the last decade, research has clarified the binding interactions between immunoglobulin E (IgE) and its high-affinity receptor, the FcεRI alpha chain (FcεRI). The formation of the IgE-FcεRI complex is crucial in the context of atopic allergies, linking allergen recognition to cellular activation and disease manifestation. Consequently, pharmacological strategies that disrupt these interactions are vital for managing atopic conditions. Historically, the complexity of the IgE-FcεRI binding process and challenges in producing functional recombinant derivatives has complicated data interpretation. However, advancements in structural biology, protein engineering, and immunological studies have enhanced our understanding of these protein-protein interactions (PPI), facilitating the development of more effective therapies. The introduction of anti-IgE therapies underscores the significance of the IgE-FcεRI PPI in allergic asthma. IgE, that is present locally and systemically, serves as a sensory mechanism in the adaptive immune response, particularly in mast cells (MCs) and basophils. When bound to FcεRI, IgE enables rapid memory responses to allergens, but dysregulation can lead to severe allergic asthma. Thus, the reactivity of IgE sensors can be finely modulated using various IgE-associated molecules. This review explores the mechanisms underlying IgE-dependent MC activation and its regulation by these molecules, including the latest therapeutic candidates under investigation.
format Artículo científico
id pubmed_39608548
institution PubMed
language en
publishDate 2025
publisher International journal of biological macromolecules
record_format pubmed
spellingShingle IgE-FcεRI protein-protein interaction as a therapeutic target against allergic asthma: An updated review.
Liu, Yan-Jun
Wang, Hui-Ying
Wang, Ran
Yu, Jing
Shi, Jin-Jin
Chen, Ru-Yi
Yang, Guan-Jun
Chen, Jiong
Humans
Immunoglobulin E
Receptors, IgE
Asthma
Animals
Protein Binding
Mast Cells
IgE-FcεRI protein-protein interaction as a therapeutic target against allergic asthma: An updated review. Liu, Yan-Jun Wang, Hui-Ying Wang, Ran Yu, Jing Shi, Jin-Jin Chen, Ru-Yi Yang, Guan-Jun Chen, Jiong Humans Immunoglobulin E Receptors, IgE Asthma Animals Protein Binding Mast Cells In the last decade, research has clarified the binding interactions between immunoglobulin E (IgE) and its high-affinity receptor, the FcεRI alpha chain (FcεRI). The formation of the IgE-FcεRI complex is crucial in the context of atopic allergies, linking allergen recognition to cellular activation and disease manifestation. Consequently, pharmacological strategies that disrupt these interactions are vital for managing atopic conditions. Historically, the complexity of the IgE-FcεRI binding process and challenges in producing functional recombinant derivatives has complicated data interpretation. However, advancements in structural biology, protein engineering, and immunological studies have enhanced our understanding of these protein-protein interactions (PPI), facilitating the development of more effective therapies. The introduction of anti-IgE therapies underscores the significance of the IgE-FcεRI PPI in allergic asthma. IgE, that is present locally and systemically, serves as a sensory mechanism in the adaptive immune response, particularly in mast cells (MCs) and basophils. When bound to FcεRI, IgE enables rapid memory responses to allergens, but dysregulation can lead to severe allergic asthma. Thus, the reactivity of IgE sensors can be finely modulated using various IgE-associated molecules. This review explores the mechanisms underlying IgE-dependent MC activation and its regulation by these molecules, including the latest therapeutic candidates under investigation.
title IgE-FcεRI protein-protein interaction as a therapeutic target against allergic asthma: An updated review.
topic Humans
Immunoglobulin E
Receptors, IgE
Asthma
Animals
Protein Binding
Mast Cells
url https://pubmed.ncbi.nlm.nih.gov/39608548/